| |
| |
|
| Insider
Information: |
Crowley John F |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
590,194 |
|
|
Indirect Shares
|
97,759 |
|
|
| Direct
Value |
$6,335,090 |
|
|
|
Indirect Value
|
$688,536 |
|
|
| Total
Shares |
687,953 |
|
|
| Total
Value |
$7,023,626 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-12 |
4 |
OE |
$14.25 |
$5,414,810 |
D/D |
380,000 |
708,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-12 |
4 |
AS |
$14.25 |
$5,414,810 |
D/D |
(380,000) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-03-20 |
4 |
OE |
$11.49 |
$3,082,242 |
D/D |
268,322 |
351,821 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-03-20 |
4 |
AS |
$11.49 |
$3,082,242 |
D/D |
(268,322) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-07-14 |
4 |
OE |
$15.03 |
$2,137,676 |
D/D |
142,250 |
225,749 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-07-14 |
4 |
AS |
$15.03 |
$2,137,676 |
D/D |
(142,250) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-02-01 |
4 |
AS |
$13.11 |
$1,931,342 |
D/D |
(147,316) |
1,004,669 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-03 |
4 |
D |
$13.53 |
$1,466,882 |
D/D |
(108,417) |
948,531 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-15 |
4 |
D |
$14.00 |
$1,329,566 |
D/D |
(94,969) |
602,659 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-10-05 |
4 |
AS |
$128.83 |
$1,305,391 |
D/D |
(10,000) |
2,094 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-01-15 |
4 |
AS |
$11.71 |
$1,212,296 |
D/D |
(103,500) |
668,081 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-01-20 |
4 |
AS |
$21.51 |
$1,075,325 |
D/D |
(50,000) |
859,388 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-01-15 |
4 |
OE |
$10.36 |
$1,072,260 |
D/D |
103,500 |
771,581 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-01-15 |
4 |
AS |
$10.35 |
$1,034,790 |
D/D |
(100,000) |
958,339 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-01-11 |
4 |
D |
$12.02 |
$1,000,797 |
D/D |
(83,261) |
1,012,056 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-01-09 |
4 |
AS |
$11.43 |
$972,954 |
D/D |
(85,102) |
885,229 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-12-20 |
4 |
AS |
$13.51 |
$878,929 |
D/D |
(65,075) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-12-20 |
4 |
OE |
$13.51 |
$878,929 |
D/D |
65,075 |
393,076 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-02-01 |
4 |
OE |
$5.13 |
$798,669 |
D/D |
139,929 |
1,151,985 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-17 |
4 |
AS |
$14.75 |
$777,650 |
D/D |
(52,722) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-17 |
4 |
OE |
$14.75 |
$777,650 |
D/D |
52,722 |
380,723 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2022-01-05 |
4 |
AS |
$12.18 |
$774,119 |
D/D |
(63,543) |
655,131 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2014-12-04 |
4 |
AS |
$8.36 |
$743,907 |
D/D |
(89,000) |
109,083 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2014-12-04 |
4 |
AB |
$8.36 |
$743,907 |
D/D |
89,000 |
198,083 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-06-08 |
4 |
AS |
$13.01 |
$715,550 |
D/D |
(55,000) |
83,499 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
